# Fox Chase Cancer Center and Rodon Group partner to develop COVID-19 swabs

Fox Chase Cancer Center partnered with plastic injection mold company The Rodon Group to develop nasal and oral collection swabs for COVID-19 testing. Rodon could produce 40-50 million swabs per year once equipment is set up.

- Type: Partnership
- Announced: 2020-08-19
- Where: Hatfield, Pennsylvania, United States
- Status: announced
- Capacity: 40000000 to 50000000 swabs per year
- Products: COVID-19 nasal and oral collection swabs
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Fox Chase Cancer Center](https://endata.com/companies/49278.md) (partner)
- [The Rodon Group](https://endata.com/companies/49279.md) (partner)

## Sources

- [northeasttimes.com](https://northeasttimes.com/2020/08/19/fox-chase-plastic-molding-company-partner-to-create-new-swab/), 2020-08-19: "We're going to give them as many swabs as they need as a thank you for making sure I'm on the correct side of my treatment."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.